Hims & Hers Health, Inc. (NYSE:HIMS) faces stock decline due to Eli Lilly's (NYSE:LLY) GLP-1 revenue miss. Concerns arise over Hims' compounded GLP-1 offerings.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing
Hims & Hers Health, Inc. (NYSE:HIMS) faces stock decline due to Eli Lilly's (NYSE:LLY) GLP-1 revenue miss. Concerns arise over Hims' compounded GLP-1 offerings.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing
We are preparing, please wait
This content is only available for premium members. Please become a paid member to access.
Download AppCurrently, memberships can only be purchased through the app.